Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.62 |
| ▸ | RAD52 | P43351 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 2/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.49 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.49 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1961633 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL1961134 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL1961372 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL1960270 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL224044 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL1961180 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL1958216 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL9019593 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL10901661 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL10901502 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115151527-B | Process for the preparation of cyanoacetic esters | 汉高股份有限及两合公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119930468-A | Synthesis method of medical cyanoacrylate adhesive with low formaldehyde residue | 山东禹王和天下新材料有限公司 | 2025-05-06 | — | — | CN | claimed |
| US-12187923-B2 | Michael-addition-hardening synthetic resin for chemical fixing technology | FISCHERWERKE GMBH & CO. KG (DE) | 2025-01-07 | — | — | US | claimed |
| CN-119258259-A | Vein closing adhesive, and preparation method and application thereof | 诺一迈尔(山东)医学科技有限公司 | 2025-01-07 | — | — | CN | claimed |
| US-12180394-B2 | Michael-addition-hardening hybrid system for chemical fixing technology | FISCHERWERKE GMBH & CO. KG (DE) | 2024-12-31 | — | — | US | claimed |
| CN-119039178-A | Preparation method of alpha-cyanoacrylate and medical adhesive | 深圳聚环科技有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-118598885-A | Side chain modified benzodithiophene small molecule donor material and preparation method and application thereof | 青岛大学 | 2024-09-06 | — | — | CN | claimed |
| CN-118063347-A | Process for preparing alpha-cyanoacrylate for varicose vein treatment and composition thereof | 诺一迈尔(山东)医学科技有限公司 | 2024-05-24 | — | — | CN | claimed |
| US-11976024-B2 | Process for preparing cyanoacetates | HENKEL AG & CO. KGAA (DE) | 2024-05-07 | — | — | US | claimed |
| CN-114853780-B | Side chain modified benzodithiophene small molecule donor material and preparation method and use method thereof | 西北工业大学深圳研究院 | 2024-02-23 | — | — | CN | claimed |
| CN-101961506-A | Composite nano biological bone glue with osteogenesis inducing activity and preparation method thereof | SECOND PEOPLES HOSPITAL SHENZHEN | 2011-02-02 | — | — | CN | claimed |
| CN-100575337-C | The method for preparing α-Qing Jibingxisuanzhi | BEIJING KEHUA NEW MATERIAL SCIENCE & TECHNOLOGY CO LTD | 2009-12-30 | — | — | CN | claimed |
| CN-101497767-A | Preparation of alpha-cyanacrylate adhesive | XUEHANG FANG (CN) | 2009-08-05 | — | — | CN | claimed |
| CN-101096580-A | Method for improving storage stability of alpha-cyanacrylate adhesive | BEIJING KEHUA NEW MATERIAL SCI (CN) | 2008-01-02 | — | — | CN | claimed |
| CN-1130414-C | Weak Bronsted acid derivatives for improving the dimensional stability of polyurethane flexible foams | AIR PROD & CHEM (US) | 2003-12-10 | — | — | CN | claimed |
| US-6136876-A | SHRINKAGE INHIBITION | AIR PRODUCTS AND CHEMICALS (US) | 2000-10-24 | — | — | US | claimed |
| CN-1254730-A | Weak Bronsted acid derivatives for improving the dimensional stability of polyurethane flexible foams | AIR PROD & CHEM (US) | 2000-05-31 | — | — | CN | claimed |
| EP-1002816-A2 | Weak bronsted acid derivatives for improving dimensional stability of polyurethane flexible foams | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2000-05-24 | — | — | EP | claimed |
| CN-1019295-B | PREPARATION PROCESS OF HIGH-PURITY HIGH-CARBON-ALKYL ALPHA-CYANOACRYLATE | XI AN RESEARCH INST OF CHEMICA (CN) | 1992-12-02 | — | — | CN | claimed |
| CN-87103468-A | The preparation method of high-purity alpha-high-carbon-alkyl alpha-cyanoacrylate | — | 1988-11-30 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11976024-B2 | Process for preparing cyanoacetates | PCCA, ACMSD, AADAT | NAAA 8/4885RAD52 3196/4885NPSR1 1460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.